MSB 4.89% $1.07 mesoblast limited

mid november looming ....

  1. 5,344 Posts.
    lightbulb Created with Sketch. 956
    Finished on a day high thats good , trading was done by the bot most of the day .... So much happening world wide re adult v embro stem cell and most countries are starting to generate funds to adult stem cell research..Is it nice to know we have been on that road for a decade and many are just starting out on this track ... NOV 14 .. Results from the randomized, placebo-controlled Phase 2 trial of Mesoblast's allogeneic, or off-the-shelf, adult stem cell product, Revascor™, in patients with moderate-severe congestive heart failure will be presented by Dr Emerson C. Perin, Director of Research in Cardiovascular Medicine and Medical Director, Stem Cell Center, Texas Heart Institute, Houston..... I wonder if shareholders will embrace the results, but we will not know until that date .. As one analyst said if it stacks up it could be bigger than texas (My belief is and its only mine ) its going to be very positive .. Cheers Vin
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.055(4.89%)
Mkt cap ! $1.221B
Open High Low Value Volume
$1.14 $1.16 $1.06 $8.816M 8.055M

Buyers (Bids)

No. Vol. Price($)
1 280000 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 2000 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.